Literature DB >> 20889003

[Intestinal microbiota in short bowel syndrome].

O Goulet1, F Joly.   

Abstract

Short bowel syndrome (SBS) is the main cause of intestinal failure especially in children. The colon is a crucial partner for small intestine adaptation and function in patients who have undergone extensive small bowel resection. However, SBS predisposes the patient to small intestine bacterial overgrowth (SIBO), explaining its high prevalence in patients with this disorder. SIBO may significantly compromise digestive and absorptive functions and may delay or prevent weaning from total parenteral nutrition (TPN). Moreover, SIBO may be one of the causes of intestinal failure-associated liver disease, requiring liver transplantation in some cases. Traditional tests for assessing SIBO may be unreliable in SBS patients. Management of SIBO with antibiotic therapy as a first-line approach remains a matter of debate, while other approaches, including probiotics, offer potential based on experimental evidence, though only few data from human studies are available.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20889003     DOI: 10.1016/S0399-8320(10)70019-1

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  9 in total

1.  Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages.

Authors:  Nobuhito Taniki; Nobuhiro Nakamoto; Po-Sung Chu; Yohei Mikami; Takeru Amiya; Toshiaki Teratani; Takahiro Suzuki; Tomoya Tsukimi; Shinji Fukuda; Akihiro Yamaguchi; Shunsuke Shiba; Rei Miyake; Tadashi Katayama; Hirotoshi Ebinuma; Takanori Kanai
Journal:  JCI Insight       Date:  2018-06-21

2.  Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome.

Authors:  Susan Lapthorne; Prue M Pereira-Fantini; Fiona Fouhy; Guineva Wilson; Sarah L Thomas; Nicole L Dellios; Michelle Scurr; Orla O'Sullivan; R Paul Ross; Catherine Stanton; Gerald F Fitzgerald; Paul D Cotter; Julie E Bines
Journal:  Gut Microbes       Date:  2013-04-02

Review 3.  Redefining short bowel syndrome in the 21st century.

Authors:  Valeria C Cohran; Joshua D Prozialeck; Conrad R Cole
Journal:  Pediatr Res       Date:  2016-12-20       Impact factor: 3.756

4.  Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota.

Authors:  Susan V Lynch; Katherine C Goldfarb; Yvette K Wild; Weidong Kong; Robert C De Lisle; Eoin L Brodie
Journal:  Gut Microbes       Date:  2012-10-12

5.  Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome.

Authors:  Helene Engstrand Lilja; Hugo Wefer; Niklas Nyström; Yigael Finkel; Lars Engstrand
Journal:  Microbiome       Date:  2015-05-04       Impact factor: 14.650

Review 6.  Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.

Authors:  Uday C Ghoshal; Ratnakar Shukla; Ujjala Ghoshal
Journal:  Gut Liver       Date:  2017-03-15       Impact factor: 4.519

7.  Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis.

Authors:  Xiuting Hu; Wei Cheng; Shengxian Fan; Yuhua Huang; Xi Chen; Zhiwei Jiang; Jian Wang
Journal:  BMC Infect Dis       Date:  2021-06-16       Impact factor: 3.090

Review 8.  Extensive Intestinal Resection Triggers Behavioral Adaptation, Intestinal Remodeling and Microbiota Transition in Short Bowel Syndrome.

Authors:  Camille Mayeur; Laura Gillard; Johanne Le Beyec; André Bado; Francisca Joly; Muriel Thomas
Journal:  Microorganisms       Date:  2016-03-08

9.  Is it bowel-associated dermatosis-arthritis syndrome induced by small intestinal bacteria overgrowth?

Authors:  Hongjun Zhao; Lijuan Zhao; Wei Shi; Hui Luo; Liping Duan; Yunhui You; Yisha Li; Xiaoxia Zuo
Journal:  Springerplus       Date:  2016-09-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.